Welcome back to Under the Bioscope. In this episode, we explore the rapidly changing landscape of AI in healthcare and the new realities facing both patients and providers. With nearly 70% of adults now using AI chatbots for second opinions, often before they’ve even left the doctor's parking lot, physicians are under pressure to adapt and redefine the value they bring to the table. Joining us is Tom Blue, partner at OvationLab and former executive director and chief strategy officer of the American Academy of Private Physicians. Drawing on years of research into the longevity consumer, Tom shares unique insights on the evolution of patient trust, why consumers are turning to AI, and what it takes for doctors to remain a vital part of the healthcare equation in the age of powerful AI tools like Bioscope.
Timestamps:
00:00 AI's impact on longevity medicine
03:38 AI in personalized healthcare
09:56 Bias in AI models for healthcare
13:18 Trust paradox in healthcare advice
15:35 Rise and fall of DIY medicine
18:12 AI empowering patient-doctor collaboration
24:20 Advantages of Bioscope in healthcare
25:25 Enhancing health data analysis
30:55 Doctor-patient advice and AI scrutiny
32:01 AI as a healthcare partner
How AI is Transforming the Doctor-Patient Relationship: Insights from Under The Bioscope
In the latest episode of Under The Bioscope, Tom Blue, partner at Ovation Lab and former executive director of the American Academy of Private Physicians, provides an eye-opening exploration of how AI is reshaping the world of healthcare. This episode focuses on the rise of patient-driven AI adoption, its implications for physicians, and the strategies that medical practices can implement to stay ahead.
The End of the Doctor’s “Language Monopoly”
One of the most profound shifts discussed in the episode is how AI has lifted the age-old monopoly doctors held on interpreting the complex language of medicine and biology. Today, a patient can walk out of a doctor’s office, sit in their car, and immediately consult an AI chatbot with follow-up questions about their care. Accessibility, immediacy, and free resources have changed the landscape. The ease with which patients can now seek second opinions or clarify medical advice no longer requires an appointment or a gatekeeper.
Evolving Patient Behavior and AI Adoption
Drawing from Ovation Lab’s ongoing social listening studies, Tom Blue highlights that the use of AI in healthcare by consumers is exploding. Across millions of conversations, the data shows movement from speculative, future-oriented discussions toward practical, real-world AI use cases. Patients are actively using chatbots to interpret test results, receive education, build and optimize personal health regimens, and verify or cross-examine doctor recommendations. It’s no longer hypothetical; it’s reality.
The Trust Paradox in Modern Medicine
While people still regard their own doctors as the most trusted figures in healthcare, trust in the broader medical system and regulatory bodies has significantly eroded. The deluge of conflicting advice, from doctors, influencers, and AI tools, often leaves patients skeptical. Surprisingly, when faced with confusing or conflicting information about wellness, nutrition, or longevity, patients are more inclined to trust non-physician sources or AI-driven advice than their personal doctors.
AI as a Patient Empowerment Tool
Despite the risks and challenges, AI tools are playing a critical role in empowering patients to better understand their health. Ideally, AI supports a collaborative model, allowing patients to partner with their doctors, make informed decisions, and fill knowledge gaps. Patients increasingly see themselves as CEOs of their health, with doctors acting as chief medical officers, helping interpret data, plan strategies, and maximize safety.
However, patients are not satisfied with paternalistic models where doctors control access to information or care. With AI, wearable technology, and direct-access services, the cost of disengaging from a doctor has dropped dramatically. Patients who feel dismissed or unsupported can obtain tests, prescriptions, or information independently.
The Importance of AI-Proof Care Plans
As patients regularly run their doctor’s advice through AI for validation, doctors must adapt. Tom Blue argues that physicians need to create care plans detailed enough to survive AI cross-examination. This requires deeper context: who the patient is, their objectives, rationale for recommendations, and ways to measure success. Only AI-powered tools can help generate such comprehensive plans within a practical workflow.
Crucially, doctors should not appear defensive or dismissive when patients use AI for second opinions. Doing so risks eroding trust and rapport. Instead, embracing the behavior as part of a collaborative relationship helps foster confidence and satisfaction.
Differentiating Clinical AI Tools from Consumer Chatbots
While most consumer chatbots and clinical AI tools share similar functionalities, the real differentiator is context. Bioscope, a clinical AI tool highlighted in the episode, sets itself apart by ingesting extensive patient data: genomics, wearable information, medical history, and more. This depth of context allows providers to generate recommendations that far exceed the quality and personal relevance of standard consumer chatbot responses.
Looking Forward: Building Strong Partnerships with Patients
The key takeaway from the episode is clear. Physicians must evolve into collaborative partners, utilize advanced AI tools, and supply advice that is transparent and context-rich. The embrace of AI is no longer an optional add-on for innovative practices; it is a necessity for maintaining patient trust and relevance in a rapidly changing healthcare landscape.
If practices can expose patients to advanced tools like Bioscope and structure care plans for transparency and evidence, they will be well-positioned to forge lasting, productive relationships. For more insights, listen to the full episode of Under The Bioscope and discover the strategies that will shape the future of precision longevity.
Bioscope AI https://bioscope.ai/
Under The Bioscope https://underthebioscope.com/
“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”
[00:00:00] Your patient walks out of a great visit, sits down in the car, and before they've left the parking lot, they've already typed your advice into an AI chatbot. So AI, if you think about it, has broken the age-old monopoly that doctors have on what is essentially the language of medicine and biology. It's irresistible. It's so easy, it's free, and they're just going to do it. All of the friction that used to be massive cost of disengaging with your doctor is kind of gone today.
[00:00:28] The moment you become defensive about it, it's an enormous turnoff to the modern patient. And as we know, AI is never dumber than it is today, and so it will only be smarter tomorrow. And so I think this is a tendency that is not going to go away. Welcome to Under the Bioscope. I'm Leila from TopHealth.
[00:00:55] And picture this. Your patient walks out of a great visit, sits down in the car, and before they've left the parking lot, they've already typed your advice into an AI chatbot. And that's not hypothetical. In a national survey this year, 69% of adults said that they have used AI for a second opinion right after a visit. And nearly four in five never even told their doctor. So how should physicians be responding to this? Our guest has spent 20 years helping new science find its way into private practice.
[00:01:25] Tom Blue is a partner at Ovation Lab and the former executive director and chief strategy officer of the American Academy of Private Physicians. Tom, welcome. It's nice for you to be here. I'm happy to have this conversation with you. Before we dive in, how are you? Excited to be here? I'm delighted to be here. It's great to meet you, and this will be a fun conversation. Absolutely. And before we hop in, I feel like AI is absolutely everywhere, right?
[00:01:54] It's a hot topic. Everyone's talking about it. Everyone has an opinion. So let's kind of start with what you heard. So when you listen to how patients talk about AI and their doctors, what really stood out to you the most? Well, the use of AI has been such a rapidly changing thing.
[00:02:15] We at Ovation Lab are now in our fourth year of a social listening study of the longevity consumer universe, which is to say this year we probably have now mined right about 2 million consumer conversations looking at the topic of longevity through the lens of strictly the consumer.
[00:02:39] And every year we repeat our study of consumer conversations as they specifically pertain to AI because the technology is advancing so fast and consumers' use of it is advancing equally fast. And what we found is a really interesting evolution. Back in 22 and 23, there was discussion of AI as, you know, it was mostly oriented to sort of its future potential.
[00:03:05] AI, the emergence of AI actually gave rise to, and I think has been a big, has been fuel on the fire of demand for longevity medicine. One of the things about longevity consumers is, and longevity medicine in general, is it is premised on the requirement to ingest and synthesize and draw insights from more data than a human doctor possibly could.
[00:03:33] And so instead of, you know, a blood draw with 50 or 60 lab markers, you're dealing with omic data that's gigabytes large of, you know, of data sets that you could never even, you could never pretend to yourself. Add to that wearable data and other, you know, other health information that you might provide, other labs that you might do, you know, your entire medical history. So it's, you know, longevity medicine is very much about the ability to synthesize inhuman amounts of data.
[00:04:01] And so the emergence of AI has given rise to a whole new level of plausibility that we can potentially alter or control the trajectory of our health. So 22 and 23, the conversation was very much about unlocking that potential. 2024 to 2025, we were starting to see real use cases in consumer use of AI.
[00:04:25] Mostly things, and frankly, there was the opportunity in those years for doctors that wanted to be ahead of the curve on this to actually lead their patients into the use of AI for the management of their health. We did a lot of teaching in those years about how do you incorporate in your visits an ambient scribe to take notes for you, and then simultaneously, we called it the clinical triad.
[00:04:50] How do you actually bring AI into the visit and use it to hyper-personalize care plans, hyper-personalize a food plan? You know, I can remember teaching, actually, one of our team members taught a really interesting use case that involved, it was a case study, actually, of a long-distance truck driver, and taking that guy's food plan and turning it from sort of this absurd thing that in a truck, you're never going to be going to the grocery store and preparing meals,
[00:05:20] to a plan that actually involved menus of the restaurants on his route from here, from this part of the country to that part. So it was like completely personalized and completely feasible, which was at that time pretty remarkable. And so imagine if your doctor did that. Well, here we come into 2026, and we look at the consumer use cases, and I would venture to say that in the longevity community,
[00:05:48] the opportunity to kind of introduce your patients to the use of AI for health has largely passed doctors by. We now are seeing signals of consumers setting up their own agents to mine their wearable data and to mine news on the frontier of longevity, new longevity drugs. I mean, it's really pretty amazing, the use cases that consumers are setting up for themselves. And so there's this evolution of kind of the use of AI.
[00:06:17] We also saw an evolution in the way that consumers wanted their doctors to interact with AI. And so it began with consumers really being inspired by seeing their doctors become early adopters of AI and carry that all the way to this year, where we were picking up signals that were essentially consumers saying, well, your future doctors in med school cheating their way through using ChatGPT
[00:06:47] now might be a good time to take control of your own health. And so this idea that the doctor's using the same tools as you are as the patient, you know, seems less exciting. And so it introduces a whole new kind of set of challenges for doctors to bring AI, to create value for patients using AI. And I would say that this is the year where if you could create an advantage for a doctor
[00:07:16] in the form of an objectively better tool than the consumer has access to, which is not an easy advantage to create, that would be the thing that you would want to do. And as it relates to Bioscope, Bioscope is the first and only tool I've run across that creates that objective advantage that any consumer would understand, that the answers you're fetching from Bioscope are going to be simply better
[00:07:44] than the answers you yourself can get, no matter how good you are at prompting. Absolutely. And that kind of does lead me into my next question, but it is kind of interesting to think about it because patients and just people in general are using ChatBots and AI, like you said, with their own prompts. And it is a helpful tool for patients, for physicians, for everyone. It can be a helpful tool.
[00:08:06] But there's also this idea from sometimes from patients and just people in general that they can just rely on ChatBots, which is really not the case. It could be helpful in certain scenarios, but you still need a physician, especially when it's health-related or anything else. It's a tool, but it can't be everything from a patient standpoint. So with that being said, let's talk about that parking lot moment we mentioned earlier in the episode.
[00:08:35] So what do you think patients are actually doing when they do run to their doctor's advice through a ChatBot right after that first visit? What do you think that they're doing? Yeah. Well, when we studied the, we asked the question of our data, which is what are the top uses of AI by consumers? And essentially, you come up with a handful of use cases. One is kind of education and interpretation. So AI, if you think about it, has broken the age-old monopoly
[00:09:05] that doctors have on what is essentially the language of medicine and biology. It used to be, not long ago, if you had a real medical question, you had to book a medical visit with a doctor, ask your question, and get your answer. And today, AI has broken that monopoly. And you can read a study that you don't understand, load it into CLOT or ChatGPT, ask it to tell you the answer, and it will spit out that answer in layman's terms
[00:09:32] and continue to dumb it down until you feel like you've really gotten it. And so learning how to up-level your knowledge and understanding to be approximate in parity with a doctor is use case number one. The second use case is optimizing protocols, food plans, supplement stacks, kind of building your regimen and program and optimizing it. Interpreting lab results is another kind of use case in that number one category.
[00:09:59] Then the third is what I would call verification and skepticism, which is this parking lot moment you're describing. And so essentially, it's become so easy to get a second opinion on things that consumers, especially the longevity consumer, I think it's a safe assumption for longevity practitioners to say, 100% of my patients are going to second guess what I'm saying and load it into ChatGPT. It's irresistible.
[00:10:29] It's so easy. It's free. And they're just going to do it. And so what that means for the practitioner is that they need to provide their care plans in a way that can survive that type of cross-examination. And so the problem that practitioners are running into is that ChatGPT, Claude, these publicly available models are all very biased in the direction of conventional medicine.
[00:10:57] They're trained on overwhelmingly the sources that come back when you look at the sources for responses to our prompts, are all NIH-related sources, PubMed. The models are, understandably, they're biased to conventional thinking. And longevity medicine, by definition, is sort of pushing the frontier of what's possible and oftentimes relies on things that deviate from conventional and traditional medical approaches.
[00:11:25] And so in order to enable a care plan to withstand the scrutiny of AI, you've got to write the care plan in a way that goes far deeper into the explanation of who this patient is, what their objectives are, how you arrived at your decision, how you're going to track whether this care plan is working and what you're going to do if the care plan's not going to work. And so it's a type of care plan that can only be created by AI
[00:11:54] in order to survive the cross-examination of AI. It would take far too much work for it ever to be practical, for a doctor to make a care plan like I just described to you. But with the assistance of AI, it's possible. And we have to assume that patients are going to do this. Now, here's another thing we've learned looking at consumer trust in healthcare providers. The one thing doctors cannot do is roll their eyes and frown on the tendency
[00:12:22] that we all now have to cross-examine everything with AI. The moment you become defensive about it, it's an enormous turnoff to the modern patient. Absolutely. And touching on that, I think one thing you said was about the care plan and the longevity plan. It would take far too much time that we wouldn't really be able to get that from a physician just initially. There's so much information to kind of create those care plans.
[00:12:51] But you also touched on skepticism and second opinions. So I kind of want to dive into that a little bit. So do you think that that's a sign that patients don't particularly trust their doctors? You know, it's very interesting. The consumer trust in the institution of healthcare has plummeted since 2020, since COVID. And this is a global phenomenon.
[00:13:20] I mean, so it's certainly true in the U.S., but it's true everywhere. And so when you think about the—and what it's born out of is just the obnoxiously conflicting information we're all bombarded with. The, you know, we are—you know, there is the conflicting information even from doctors, from influencers. It's just, you know, should you be vegan? Should you be paleo? Nothing you can't—no one agrees on anything.
[00:13:46] And so when you then overlay what feels like the politicization of health, you know, that we've seen with COVID and vaccines and, you know, it's now politics has now entered into the equation and seems to play a role. It's, you know, it has just undermined the heck out of our collective trust in, call it, the medical institution. Now, when you look at regulatory bodies, the FDA, companies involved in healthcare that make
[00:14:15] money from it, obviously trust in them has been undermined far greater than trust in doctors. Doctors remain—our doctors remain the most trusted kind of entity in the healthcare ecosystem. Now, what's interesting is that despite the fact that the vast majority of Americans, like well north of 80 percent, who have a doctor relationship regard that relationship as trusted,
[00:14:40] in the face of conflicting information, especially when it relates to your future wellness, nutrition, longevity, diagnosing of a disease less so, but when it relates to the trajectory of your health, in the face of conflicting information, most of the time consumers will trust the other source that is not their doctor.
[00:15:04] And so one of the things that, you know, that we're learning is, is that doctors are very trusted when a bone is broken, there is a disease to be diagnosed. But the more you get into proactive rather than reactive management of your health, you know, think healthcare is a body repair shop, the doctor is where you go.
[00:15:29] If I want to control the future of my health, consumers have become conditioned to think that the better advice lives with trainers and nutrition professionals and influencers and folks that other patients that share their lived experience actually carries a lot of trust, as does AI. And so it's a really, really interesting, almost trust paradox, where we do trust our doctor,
[00:15:58] or we don't consider our doctor untrustworthy. However, in the face of conflicting information about future-looking health, you know, health objectives, in the face of conflicting opinions, you know, our doctor tends not to win out. That's such a, that's a really, really good, good, good point. My mind is like all over the face with that because I'm thinking it out in the moment. And it is, it's like there is so much conflicting advice.
[00:16:25] And it's like you said, like if you have a broken bone or a disease or something that you can fix by looking it up, right? There's something that you can change. Then that's when everyone goes to the trust of the provider. But if you could look it up and this chatbot has your history and you've seen all this, you know, videos and these people speaking about things online, it's almost like it's more apparent. It's, you're, you're looking at these, you're consuming this information every day.
[00:16:51] So it makes it almost seem, you know, where your trust kind of goes. That's very true. You know, I'll tell you, there's an interesting thing. When you look at just the evolution of consumer trust over the last three or four years, right around mid 2025 was, was, was kind of the peak of the first era of call it do-it-yourself medicine, where consumers relied primarily on friends, family and social media type influencers. Some of whom have medical credentials, many of whom do not.
[00:17:18] They have, they have what appears to be lived experience that, that drives, that drives the trust. By the, by mid 2025, roughly half the population, more than half of people under the age of 35, a little less than half of people over 35 were living with some regret about a health decision that they had made over the prior year, year and a half, sort of relying on, on that source of advice.
[00:17:43] Now, you would think that at the, at the end of that era, as we now have this big regret cohort of patients, that these patients would be heading back to their doctor hat in hand and saying, you know, I went out on my own thought I could be my own doctor with the help of TikTok, you know, and my friends and family and my trainer. And it turns out that was a disaster. Please tell me what to do from now on. That's actually not what happened. The next era of do-it-yourself medicine, sort of while that debacle was going on,
[00:18:12] what's been happening in the world of AI? Well, the tools get smarter and smarter and smarter. And so by mid to late 2025, the tools had sort of elevated themselves to the place where it's like, I'm no longer going to put all my faith and confidence in friends, family and influencers. I'm now going to shift more of my weight to the use of AI. And as we know, AI is never dumber than it is today. And so it will only be smarter tomorrow.
[00:18:38] And so I think this is a, this is a tendency that is not going to go away. No, absolutely not. And I think while you were talking about that, all I kept thinking of was, was COVID. Yeah. Because people had to, you know, start searching for a lot of their own things. And that was before AI is obviously what it is today. But if people are sick or, you know, not feeling the best or whatever it may be, we weren't just going to the doctor unless it was kind of urgent.
[00:19:03] So we also became like so self-reliant before, before the AI is what it is today. So I think that that combination really, you know, enforced what we have now. Yep. And with that being said, where do you think, or where does consumer AI lead patients kind of astray? What we can see very clearly in the, in the, in our social listening data is the, and this has been un, unwavering for the four years we've been studying this.
[00:19:32] What consumers want from their doctor is a partnership. The role that AI, that in the perfect world, AI would play is it enables the, the patient to be a better collaborator with their doctor. It has infinite time and infinite patience to sort of shore up their understanding and their literacy in whatever topic in health is important to them.
[00:19:58] And so, and so there are two avenues that people, that people wind up having to take because it is so incredibly hard to find a medical partner in the form of a doctor. They're out there, but they're very hard to come by. So many patients now are, are choosing to sort of strike out on their own and, and, and create sort of health autonomy for themselves using AI. And it's a, you know, it's a, it's a possibility.
[00:20:26] I mean, you, you, you, it's a, it's a treacherous one, but it's, you know, but, but faced with the alternative of the outdated kind of paternalistic model of healthcare, where the doctor is going to tell you what you can and can't do, and they're going to refuse to order that test that you want. And it's not a partnership. People are inclined to say, you know what? I'm going to strike out on my own. The best scenario is when a patient is both invested in their health and in an, in a,
[00:20:55] in a trusting partnership with a provider and the model, the, the, the relationship framework becomes for the future that the patient is the CEO of the enterprise, which is their own health. They get to decide how much effort they're going to put into different activities, what activities they're going to engage in, how much money they want to invest, how much time they have, what their primary goals are. And the doctor is playing the role of the chief medical officer.
[00:21:22] And so the doctor's there to maximize safety in the patient, in, in achievement of the goals that are important, important to the patient. They're helped to, they're helping to interpret data, plan strategy. They're not there to tell the CEO what they can and can't do. They're here. They're there to essentially enable the CEO to get to his or her goals with, with as little effort and as little expenses as possible with the greatest degree of safety.
[00:21:48] And if you can find that partner, it's the best possible scenario. If you can't, AI becomes every month a more and more capable surrogate for that. But it is, it's, it's far from optimal and it's far from desirable. It's not the first choice of the consumer. But here's one thing that, that we have to keep in mind that, that, that practitioners have to keep in mind is as time is marching on and technology's marching on, a few things
[00:22:16] have created a great deal of fragility in the doctor patient relationship. Number one, AI, AI broke the monopoly on needing to go to the doctor to interpret health information. So I no longer, it used to be if I need, I need an answer question, got to book an appointment. It used to be if I needed a lab test ordered, I needed to go get a doctor's appointment and they needed to agree to order that test for me. Now there's a hundred ways we can go get whatever lab tests that we want ourselves. So that monopoly is broken.
[00:22:46] It used to be if I needed to have imaging work done, say I wanted a whole body MRI, I needed to go. I mean, the doctor would think you were crazy, but you'd certainly have to go ask the doctor for it today. Prenuvo, Ezra, there's all these places we can go to book a whole body MRI. It used to be if I needed a prescription, I needed a doctor's appointment and a doctor that would agree. Today, your doctor disagrees. There's a hundred online telehealth practices that will write that prescription for you.
[00:23:15] So as you can hear, it's like all of the friction that used to be massive cost of disengaging with your doctor is kind of gone today. And so to the extent that the doctor triggers the patient with the old school paternalistic approach, scare tactics, refusal to learn something new, the easier it is for the patient to walk out into the parking lot. And by the time they get home, they've got their hormones or what have you from, you know,
[00:23:44] from, you know, an online telehealth provider. One of the things that has been, it's sort of been a dirty secret of medicine forever is something that a lot of people have referred to. It's a studied thing called the translational gap, which is the time that it takes for a new best practice in medicine. That's been proven from the time it's proven to the time that it becomes a part of the expected
[00:24:08] medical experience that you or I or anyone else would have out in the system is absurdly long. Would you care to guess how much time lives between when a best, a best practice has been proven to when it shows up in the day-to-day practice of medicine? I'm also going to express fairly quickly. I don't know. Yeah, it's the people who've researched it say it's 17 years. My perspective is, is that's actually quite conservative. Medicine has been evolving.
[00:24:38] The medicine that you experience out in the system has been evolving at sort of a generational pace. And that's been kind of unnoticed by consumers up until now. But today, a light has been shined on this. And by virtue of all the new tools at our disposal, you can see, I mean, take peptides as a great example. The conversation around peptides absolutely exploded in the last year.
[00:25:06] The number of doctors that know anything about peptides or how they might be used safely is a tiny fraction of the total doctors in practice. And consumers aren't willing to wait. They're just not willing to wait anymore for their doctor to decide that they want to learn something new. And it's not all the fault of the doctor, I might add. Most doctors are trapped on a treadmill in the healthcare system, their fee-for-service,
[00:25:34] payer-based treadmill that requires them to see 30 patients a day and refer patients for this to that. It's, you know, they're trapped in a system that burns them out, creates moral injury over this very issue. And it's not until they can break free of that system that they really have the potential to do what the modern patient needs. Longevity physicians are characterized by having kind of broken with the system and they
[00:25:58] are moving forward in a different financial relationship with patients, which makes all of this possible. Absolutely. And then also speaking about that, when most patients kind of can't really tell a consumer chatbot from a clinical tool the way physicians can, right? So what is the real difference? Well, I mean, the truth of the matter is, with very, very few exceptions, and Bioscope is the
[00:26:28] one that comes right to mind, there's really not that much difference. It's, you know, it's, there may be some skill in prompt engineering that doctors that have spent some time with this would have that patients don't, although now the AI itself can help you to optimize your prompting. And so the thing that, to me, is what separates Bioscope as a tool that is dramatically better
[00:26:57] than anything the patient has access to is its unlimited ability to ingest context about the patient. So anybody that's ever, that's ever read an article about how to generate a prompt and get the best answers out of AI have read that the best answers come when you give the AI context about the problem that you're trying to solve. And the more context that you give it, the better the answer is for, you know, for solving the need that you yourself have.
[00:27:24] So in healthcare, context might be a robust story about, about your health, which is what patients tend to try and put in. Sometimes it's not a robust story. They just, you know, they're just asking very simple questions about their health. And so with very little context comes a wide range of quality in, in the answer that you get. You could tell a very big story about your health and write a page or two. And that's more context.
[00:27:51] What I love about Bioscope is imagine loading as context, your entire genome, a couple hundred gigabytes of data, all your wearable data, your entire medical record, all your past labs, your visit notes, the supplements that you're taking, the medications you're on. It would, it's, it's an, it's an amount of context that would be literally impossible for a consumer ever to enter in.
[00:28:15] And so because Bioscope works from a base of context, that's beyond by, by many orders of magnitude, what a consumer can provide the quality of the answer, all other things being equal, the quality of the answer will be orders of magnitude better. Now add to that, the additional work that Bioscope has done to enhance the ability of the model to provide answers on the frontier of health and longevity.
[00:28:43] And now you have sort of a double advantage that separate the doctor's tool set from the patient's tool set. And to the extent that that can be on display for the patient and theater is a very important component of this. You need to, you need to expose the patient to this capability. It's a, it's a very, very different. Once you understand it, it's a very difficult thing not to be attracted to. No, I could only, absolutely.
[00:29:09] And with that being said too, what does a preemptive approach kind of look like? How does a practice kind of go about getting ahead of that parking lot scenario instead of having to be in a position where they have to react to that? Well, there are two ways. A practice that is equipped with a tool like Bioscope would expose the patient to the capabilities
[00:29:35] of the tool such that the confidence is created in the plan that's been created in collaboration with that tool. And so if I, as a patient, understand, hey, look, I just provided everything I can say about my health and this tool also houses the entirety of my genome, my wearable data, my lab data. And the answers, you know, therefore are going to be the best possible answers that could be got. Couple that with the skill of the doctor that I'm working with.
[00:30:05] Yeah. So it's kind of like in that case, what good does it now do me to take the plan that was generated by Einstein and hand it over to, you know, a lesser, a lesser brain to criticize it? Do you see what I mean? So that would be one way of doing it is to make sure the patient sort of understands the superiority of the tools that have generated the plan they've just been handed. The alternative way of doing it is to actually produce a plan and you can do both.
[00:30:33] You can produce a plan that's actually structured in a way and articulated in a way that anticipates the cross-examination of the AI. And again, only AI can make a plan like that because it requires citations and the things that we just discussed. But you hand that plan to the patient and you invite them to say, look, drop this into Claude, ChatGPT, whatever tools you use. See what it has to say.
[00:30:58] You might go so far as to actually prescribe the prompt itself and say, hey, look, if you're a little newer to AI, you might just type in this, attach your plan, type in this prompt and let that prompt go to work. And then to the extent you spot anything in that response, make note of it. Let's put that, let's make that an agenda item for our next conversation. Now you're in a partnership. Can you even imagine if a doctor did that? It would be mind-blowingly awesome. Right.
[00:31:28] So it's now, how many doctors do that today? Very, very few. Very few have the tools to do it. In fact, none do. Where this concept of building an AI-proof care plan is a very, very cutting-edge concept because it's a new problem that we're just now learning to solve. Right. And exactly touching on that, physicians are starting to adapt AI fairly quickly as well, even though it's not all there yet.
[00:31:55] But what should a physician kind of demand from the AI that they are going to bring into their own practice? Well, I mean, there's the table stakes of security, as an example. You're going to load patient information and you need to know that it's secure. I mean, to me, the grading of an AI tool for a doctor has a great deal to do with the amount
[00:32:24] of context that can be housed on the patient. So, you know, if you take Bioscope at the far end of that continuum, where you can house all your whole body MRI images, your genome, your microbiome, your wearable data, there's no data source that can't be ingested by it on one end of the continuum. If you step back a giant leap, the next level might be that the AI tool enables you to chat
[00:32:53] with and interrogate the medical record of a patient. So what's in the electronic health record? You know, stepping back from that, where you have to build the context on every patient, now you're getting into a very blurry ground where the tools you're working with are hard to distinguish from the tools the consumer, him or herself, is working with. And so, you know, again, security remains an important characteristic of it.
[00:33:20] But it becomes much harder to separate yourself and your capabilities from your patients if you're going all the way back to that level. Absolutely. And, Tom, one last one. So let's say a patient is sitting in the parking lot right now listening or sitting there with their chatbot open, right? What do you wish that their doctor had said before they walked out of that office?
[00:33:46] I think probably the most important thing for that doctor-patient relationship would have been, number one, I would hope that the advice they've provided the patient has been in a format that has the highest possible chance of withstanding the scrutiny of the AI cross-examination that's about to occur.
[00:34:11] And odds are, I mean, just imagine a naked list of a few supplements your doctor told you to take. You go out in the parking lot and say, my doctor just told me to take berberine, fish oil, vitamin D, and a probiotic. You know, should I take them? You know, and maybe these brands, should I take them? Well, you know, I mean, the AI, it'll go and look at the evidence or whatever for these supplements not really knowing what your health objectives are. Or it might look at pricing and say, oh, that's a practitioner brand and you can get it cheaper at Costco.
[00:34:40] You know, it's the odds of getting a good answer from that simple grocery list of things to do is going to be very low. And so you would wish that the patient had received the plan in a way that gave them a good chance of getting a constructive value-added answer from the AI. Today, most of the, today it's almost certain that they did not. The, you know, the second thing is, is that, is that I would love to think that the patient is in the parking lot
[00:35:07] interacting with the AI, not feeling like they have to do it in secret from their doctor. They're not cheating on their doctor to, you know, by doing this, but that actually is a part of the partnership that they're engaged in. And so the use of the AI doesn't drive the, drive fragility in the relationship. It's a part of the way the relationship works. That's definitely, definitely a good point. And Tom, thank you so much. Where, with all, you've had so many, so many good points today.
[00:35:36] I'm sure a lot of people are going to want to keep up with you. Where can anyone and all of our listeners follow your work? Well, folks, you can find us, you know, at ovationlab.com. You can contact me by way of that, you know, of the site. We, you know, we'll hit the conference circuit and be, you know, we do talks on this. We do a lot of research, as you can hear, and we do a lot of, you know, we do a lot of then unpacking of that research in, you know, and mostly in conference settings. Awesome. Sounds good.
[00:36:05] And for everyone listening and physicians, if you're listening, if you want AI that works inside your practice, sees the whole patient and shows its evidence, try it on yourself at bioscope.ai backslash try-it-yourself. We'll make sure it's links below. And make sure you share this with a colleague whose patients are already asking, chatbots, all this information. And make sure you follow under the bioscope, wherever you listen, precision longevity up close. Tom, thank you so much. It's been a pleasure speaking with you.
[00:36:35] And for our listeners, we will see you next time and have a great rest of your day.

